Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Vistagen Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 74 | 101 | +27 |
| Shares | 105.9M | 123.5M | +17.6M (+16.6%) |
| Value | $225.2M | $389.0M | +$163.8M (+72.7%) |
New holders (46)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (19)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 2,828,450 | $6.02M |
| Marshall Wace, LLP | 1,062,252 | $2.26M |
| ExodusPoint Capital Management, LP | 321,072 | $684.0K |
| HRT Financial LP | 167,466 | $356.0K |
| Capstone Investment Advisors, LLC | 125,148 | $267.0K |
| LMR Partners LLP | 84,775 | $181.0K |
| Virtu Financial LLC | 62,124 | $132.0K |
| Jefferies Group LLC | 28,900 | $61.6K |
| Financial Advocates Investment Management | 23,097 | $49.0K |
| GWM Advisors LLC | 22,300 | $47.0K |
| Atom Investors LP | 19,179 | $41.0K |
| Two Sigma Securities, LLC | 12,897 | $27.0K |
| First Republic Investment Management, Inc. | 10,000 | $21.0K |
| Sciencast Management LP | 10,000 | $21.0K |
| International Assets Investment Management, LLC | 2,750 | $6.00K |
| Wells Fargo & Company | 863 | $2.00K |
| NVWM, LLC | 1,000 | $2.00K |
| Burleson & Company, LLC | 350 | $1.00K |
| Harel Insurance Investments & Financial Services Ltd. | 200,000 | – |